FDA Approves Unknown Drug — TARO

# FDA Approves TARO's Generic Drug Application Taro Pharmaceutical Industries has received FDA approval for ANDA 079204, expanding its generic drug portfolio and positioning the company to capture additional market share in the competitive generic pharmaceuticals sector. The approval strengthens Taro's ability to serve cost-conscious patients and payers seeking alternative treatment options.